ANDA 211222, held by Nephron Pharmaceuticals. Sterile Water for Injection.
As of Nov 21, 2026, ANDA 211222 (Sterile Water for Injection), held by Nephron Pharmaceuticals, was first approved by FDA on Feb 10, 2021, with 0 approved supplements and 0 published complete response letters.
This parenteral preparation is indicated only for diluting or dissolving drugs for intravenous, intramuscular, or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 10, 2021 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Sterile Water for Injection100% (5ML) · liquid;n/a | Sterile Water for Injection | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters